Mimicking enzyme function and increasing performance of naturally evolved proteins is one of the most challenging and intriguing aims of nanoscience. Here, we employ DNA nanotechnology to design a synthetic enzyme that substantially outperforms its biological archetypes. Consisting of only eight strands, our DNA nanostructure spontaneously inserts into biological membranes by forming a toroidal pore that connects the membrane's inner and outer leaflets. The membrane insertion catalyzes spontaneous transport of lipid molecules between the bilayer leaflets, rapidly equilibrating the lipid composition. Through a combination of microscopic simulations and single-molecule experiments we find the lipid transport rate catalyzed by the DNA nanostructure to exceed 10 7 molecules per second, which is three orders of magnitude higher than the rate of lipid transport catalyzed by biological enzymes. Furthermore, we show that our DNA-based enzyme can control the composition of human cell membranes, which opens new avenues for applications of membrane-interacting DNA systems in medicine.
Main Text
The two leaflets of a mammalian cell's plasma membrane are made up from chemically distinct mixtures of phospholipids 1 . Control over the asymmetric partitioning of phospholipids is critically important to the cell's health and functions. Thus, a loss of the asymmetry can trigger unregulated apoptosis 2 and could lead to development of Alzheimer's disease 3 . Three groups of enzymes -flippases, floppases and scramblases 4,5 -can move lipids from one leaflet to the other. In contrast to flippases and floppases that require energy input for maintaining the asymmetric lipid composition, scramblases are activated to rapidly and passively dismantle the asymmetric partitioning of the lipids, which typically occurs during critical events such as cell activation, blood coagulation and apoptosis [6] [7] [8] [9] . Defects in the enzyme-catalyzed scrambling of membrane phospholipids in blood cells could hinder thrombin formation and lead to Scott syndrome 10 . Impaired lipid scrambling has been shown to weaken the immune system and evoke the autoimmune response by exposing self-antigens 11 . Thus, development of biocompatible and easy to adapt synthetic analogues to repair and/or control lipid scrambling activity in cell membranes is of considerable medical interest.
So far, membrane-spanning DNA nanostructures have emerged primarily as synthetic mimics of biological membrane channels [12] [13] [14] [15] [16] [17] [18] [19] [20] . Critical for lipid membrane insertions of DNA nanostructures was their decoration with hydrophobic anchors 12, [14] [15] [16] [17] [18] [19] [20] as the bilayer's hydrophobic core presents a high energetic barrier for DNA 21 . Recently, we have shown that a porphyrinmodified and membrane-inserted single DNA duplex promotes formation of a toroidal waterfilled pore surrounding the duplex 18 . Here, we utilize the DNA-induced toroidal pore to design a fully functional synthetic scramblase that facilitates mixing of lipids from the membrane's leaflets several orders of magnitude faster than any known biological scramblase. For the first 3 time, a de novo designed DNA-made enzyme outperforms its biological prototype. This is remarkable given that the catalytic rates of previous enzymatically active DNA nanostructures fall orders of magnitude behind natural benchmarks 22, 23 . We have designed a DNA nanostructure consisting of eight chemically synthesized DNA strands, two of which are modified with a covalently linked cholesterol group on their 3′ ends ( Fig. 1 ; for design details and sequences see fig. S1 and Table S1 ). Diluted in a salt buffer containing Mg 2+ -ions and following a previously described temperature annealing protocol 16 , the strands self-assemble into four interconnected DNA duplexes with a designed length of ~13 nm (Fig. 1A) . The hydrophobic cholesterol modifications, which are necessary to anchor the charged nanostructures into a lipid bilayer, are strategically positioned in the center of the construct 4 pointing diagonally away from the central pore ( Fig. 1B) . To verify the folding and incorporation of these hydrophobic tags into the nanostructure, non-denaturing polyacrylamide gel electrophoresis (PAGE) was performed on constructs folded from either eight unmodified DNA strands, or with one or two cholesterol-modified oligonucleotides (Fig. 1D ). The gel shows intensity bands that, at the same experimental conditions, shift towards shorter run lengths with every additional cholesterol moiety. The observed shifts are consistent with the increased molecular weight and cross-sections of the modified DNA nanostructures, which confirms their successful assembly and incorporation of the cholesterol tags. PAGE was performed without surfactants, demonstrating that no detergents are necessary to form our monomeric, functional constructs.
Having experimentally validated the feasibility of folding our cholesterol-modified DNA nanostructures, we used the all-atom molecular dynamics (MD) method to determine if the structures could induce lipid scrambling when inserted into a lipid bilayer. Following a previously described protocol 18 , we built an all-atom model of the DNA nanostructure embedded in a DPhPE lipid bilayer membrane and solvated in 1 M KCl. The entire system was first equilibrated for ~230 ns having the DNA nanostructure constrained to its initial idealized conformation, allowing for lipids and water to adopt an equilibrium configuration where the lipid head groups form a toroidal pore around the nanostructure ( Fig. 2A ; see Supplementary Methods I for detailed description of the simulation protocols). The system was then simulated without any constraints for ~2 µs (Fig. 2B ). Comparison of the initial and the final configurations reveals that several lipids have completely transferred from one leaflet to the other through the toroidal pore ( To quantitatively characterize the inter-leaflet transport of lipids, we computed the Z coordinate of each lipid's phosphorous atoms and its radial distance from the center of the DNA nanostructure, R, as a function of the simulations time ( fig. S3 ). Figure 2D shows an example of a typical translocation, where a lipid molecule is seen to move from the bottom leaflet (Z > −1.75 nm) to the top one (Z > 1.75 nm), approaching the DNA nanostructure (R < 3 nm) during the transfer process. Supplementary Movie S1 illustrates this permeation trajectory. Defining an inter-leaflet transfer event as such where the phosphorus atom of a lipid molecule changes its Z coordinate from < −1.75 nm to > 1.75 nm or vice versa, we plot in Fig To accurately determine the rate of lipid scrambling and its dependence on the pore-tolipid ratio, we built a coarse-grained Brownian dynamics (BD) representation of the toroidal pore surrounding a DNA nanostructure. In our BD model, the head groups of the lipids are represented by point particles (beads) whereas the presence of all other components of the system, including the DNA nanostructure, the lipid tail, and the electrolyte solution, are modeled implicitly. The bead-bead interaction is described by a short-range repulsive potential ( fig. S5 ); the diffusivity of each bead depends on its radial distance from the center of the nanostructure Figure 3A illustrates the distribution of the lipid head groups at the beginning and after 48 µs of a BD simulation. A significant proportion of the beads migrated from one leaflet to the other, through the toroidal pore (Supplementary Movie S5 illustrates a typical BD trajectory). Figure 3B shows the Z coordinate of two representative beads in BD simulations of the system containing a lipid patch L = 24 nm on side. Using the same definition of an inter-leaflet transfer event as in the analysis of the all-atom MD simulations, one can identify five transfer events in Figure 3B . Defining the time interval between two consecutive transfer events as τ and taking all lipid head groups into account, we obtain a normalized probability of observing a transfer event, Figure 3C . The result can be fitted by an exponential distribution e (−t/τ) /τₒ, yielding the average transfer rate, 1/τₒ, of 23 ± 1 µs −1 .
To determine the rate of lipid scrambling k from BD simulations, we count the number of lipids that have never ventured to the other leaflet as a function of simulation time and fit the resulting dependent by a single exponential function e −kt (Fig. 3D ). As expected, the scrambling rate k depends on the system size: faster scrambling is observed for smaller lipid-patch systems in the presence of the same DNA nanostructure.
In experiment, a low fraction of fluorescently labeled lipids is used as tracers to assess lipid scrambling as described below. In our simulations we mimic such selective labeling by randomly choosing 1% of all lipid heads (1 and 6 beads for L = 12 and 24 nm system, respectively) to represent the modified lipids. The number of labeled lipids remaining in their original membrane leaflet decreased in discrete steps (dashed lines in Fig. 3D ), however, when averaged over all possible realizations, the decay curve yielded the same average scrambling rate as when all lipid trajectories were used for the analysis. 9 To elucidate the dependence of the lipid transfer and scrambling rates on the pore density, we repeated our BD simulation for lipid patches of various dimensions (L = 12, 16, 20, 24 and 36 nm, Table S2 ) containing the same toroidal pore. The lipid transfer rate, Figure 3E , does not exhibit a strong dependence on the lipid patch size, which we characterize using the pore-to-lipid ratio r computed using the average number of lipids in one of the leaflets of the membrane. The scrambling rate increases with r (Fig. 3E ). The following simple mathematical expression k = r / < τₒ >, where 1 / < τₒ > is the system-size averaged transfer rate, reproduces the simulated scrambling rate. Thus, for the range of systems studied using the BD approach, lipid diffusion toward the toroidal pore does not limit the rate of lipid scrambling.
Following the computational characterization, we experimentally measured scrambling activity using a dithionite reduction assay [24] [25] [26] Fig. 4A bottom and fig. S1A ). After incubation, vesicles were imaged using confocal fluorescence microscopy. A fluorescent ring was observed in both the NBD and the DNA channel ( Fig. 4B top panel) . Their co-localization (see merged image in Fig. 4B ) demonstrates successful attachment of DNA nanostructures to the lipid vesicles 16, 18, 19 .
After focusing on one field of view and establishing the initial intensity of NBD and DNA signals separately, dithionite solution was added (4.5 mM final concentration) while recording both channels over time. Care was taken not to move vesicles during the dithionite addition, and the buffer conditions were optimized to avoid significant osmotic pressure ( fig. S10 and Table S3 ). Figure 4B S13, A and B) , which is in agreement with a previous characterization of fully activated biological scramblases that found the dithionite reduction of the NBD dye to be the rate limiting factor in the case of rapid scrambling 26 . Approximating the number of lipids per vesicle, the overall scrambling rates per vesicle were calculated to be between ~3 to 18 lipids per µs ( fig.   S13D ), which is in good agreement with the simulated scrambling rates of individual DNA scramblases. Furthermore, as the dithionite solution was added very carefully to not move the vesicles, the observed rates also include the effects of dithionite diffusion toward the vesicles.
The highest reported lipid scrambling rate in human cells was 7.8 × 10 -2 s -1 measured in platelets 27 . Previous in vitro experiments on TMEM16 scramblases 26 , opsin 25 , and rhodopsin 28 determined the scrambling rates at 10 4 s -1 under optimal conditions. In contrast, we found the simulated lipid transfer rate produced by our DNA nanostructure to be in the range of 1.9-2.6 × 10 7 s -1 , three orders of magnitude faster than measured for natural scramblases. Experimentally, our determined rates similarly surpass the reported overall flipping rates by approx. three orders of magnitude. The reason is that our 2C DNA nanostructure opens up a larger diameter toroidal lipid pore, which is also more stable than transient water passages that were previously suggested to mediate spontaneous lipid flip-flops [29] [30] [31] [32] .
In order to show the potential for in vivo applications, we tested our DNA scramblase in human cells. We incubated breast cancer cells (MDA-MB-231) for one hour with our DNA scramblases and subsequently stained the cells with FITC-labeled Annexin V which has a high binding affinity for PS lipids. As the employed cells naturally possess a low level of PS in the outer membrane leaflet 33 , Annexin V binding to untreated cells should be low. Successful 14 scrambling by our 2C DNA nanostructures would be indicated by an elevated level of surfaceexposed PS resulting in increased binding of FITC-Annexin V (Fig. 4E ). Confocal microscopy images presented in Fig. 4F show that the DNA nanostructures not only attached to the cells but also increased Annexin V binding in their vicinity. A negative control of incubating the cells with the DNA folding buffer confirmed the overall low binding of Annexin V in the absence of scrambling activity whereas a positive control using the apoptosis-inducing microbial alkaloid staurosporine showed similar maximum intensity of Annexin V binding as in the case of functional DNA nanostructure ( fig. S14, B and C) . These results demonstrate that our DNA scramblase is able to induce lipid scrambling in human cells.
In summary, we have shown that our synthetic DNA nanostructure can reproduce the biological function of a scramblase protein by inducing mixing of lipids that reside on opposite leaflets of a biological membrane in vitro and in human cells. Our synthetic DNA scramblase mixes lipids much more rapidly, outperforming both biological and reported artificial scramblases by at least three orders of magnitude 34, 35 . Equipped with an activation mechanism and ability to target plasma membranes of specific cell types, our DNA scramblase can be made suitable for biomedical applications with the scrambling activity being controlled by the geometry of the toroidal lipid pore. On demand, target cell-specific lipid scrambling can aid patients suffering from impaired lipid scrambling or be used to trigger apoptosis of intruder cells, including cells carrying cancer specific plasma membrane antigens. Furthermore, the mechanism of our DNA scramblase is independent of any cell-specific apoptosis pathways, making it applicable to a broad range of cell types. Control over lipid homeostasis by synthetic DNA nanostructures opens up a yet to be explored direction for designing personalized drugs and therapeutics for a variety of health conditions. Ultimately, the ability to outperform naturally 15 evolved proteins allowed for a glimpse at the tremendous opportunities still to be explored in nucleic acid based nanotechnology. 16 
Methods

All atom MD simulations of lipid scrambling
The caDNAno design of the DNA nanostructure ( fig. S1A ) was converted to an idealized all-atom representation and embedded into a lipid bilayer membrane using a previously described method 18 . The resulting model was merged with a rectangular volume of electrolyte solution, minimized and equilibrated in the constant number of particles, temperature and pressure ensemble. The simulations employed CHARMM36 parameter set 36 and were carried out using both NAMD 37 and Anton 38 . Supporting Methods I provides a detailed account of the simulation procedures.
BD simulations of lipid scrambling
The BD simulations were performed using our in-house GPU-accelerated program Atomic Resolution Brownian Dynamics 39 . In our BD simulation, lipid head groups were modeled as point particles that interacted with each other via a repulsive potential. All other components of the systems, including the DNA nanostructure, the lipid tails and the electrolyte solution, were modeled implicitly. Position-dependent potential was used to confine motion of the lipid head groups to the volume they occupied in the all-atom simulations; the all-atom MD trajectories were also used to determine position-dependent diffusivity of the head groups. In the Supplementary Methods II, we provide a detailed description of the simulation procedures.
DNA nanostructure assembly
All reagents were acquired from Sigma-Aldrich if not stated otherwise. DNA nanostructures were designed using caDNAno 40 and sequences optimized to minimize undesired hybridization sites. All DNA oligonucleotides were acquired from Integrated DNA Technologies (IDT).
Unmodified DNA strands (purified by standard desalting) and 3′-Cy3-modified strands (HPLCpurified) were ordered pre-diluted to 100 µM in IDTE buffer (10 mM Tris, pH 8.0, 0.1 mM EDTA) and stored at -20 °C. Cholesterol-tagged DNA strands were modified at the 3′-end via a 15 atom triethylene glycol spacer, purchased HPLC-purified, diluted to 100 µM in Milli-Q water (Merck Millipore) upon arrival and stored at 4 °C. DNA nanostructures were assembled analogously as described previously 16 . Briefly, an equimolar mixture of 8 DNA strands was Table S3 for detailed buffer conditions). Incubation with DNA nanostructures: DNA nanostructures with two cholesterol and two Cy3 tags were assembled as described above but in PBS at pH 7.4 supplemented with 8 mM MgCl2 instead of TE20 buffer. 120 µl of assembled structures were added to cells (prepared as described above) in the well plate (final structure concentration 324 nM) and incubated for one hour at 37 °C and 5% CO2. Subsequently, cells were washed with 1x Annexin V binding buffer and incubated with FITC-labeled Annexin V (Abcam) according to the provided protocol. After staining, cells were washed with binding buffer once again and then fixed in 4% formaldehyde for 15 minutes on ice, followed by three washing steps with binding buffer before being stored in the fridge overnight. On day four the cover glasses were transferred onto microscope slides by 21 mounting them with Mowiol (Calbiochem Cat. No. 475904) following a previously described protocol 41 .
Image acquisition and analysis:
Image acquisition and analysis: Images were acquired on the same confocal microscope as described for the dithionite quenching assay except that a 20x air objective was used (UPLSAPO20X/0.75). Filter set and laser power for Cy3-labeled DNA nanostructures were kept the same and parameters used for the NBD dye were applied for imaging FITC-labeled Annexin V as well. Detector voltages for both channels were kept fixed and were the same for all experiments. Z-stacks (slice thickness 500 nm) of cells were acquired with separate excitation of the 473 nm and 543 nm laser lines (sampling speed 2.0 µs/pixel). The bright field images were obtained by acquisition of the transmitted light of the 543 nm laser. Analysis was performed using Fiji.
